These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23386590)

  • 21. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
    Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X
    Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Du Y; Han X; Pu R; Xie J; Zhang Y; Cao G
    Front Med; 2014 Jun; 8(2):217-26. PubMed ID: 24748463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of
    Shi H; He H; Ojha SC; Sun C; Fu J; Yan M; Deng C; Sheng Y
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160486
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of PTPRD rs2279776 gene and interaction with hepatitis B virus mutations on the risk of hepatocellular carcinoma].
    Deng Y; Zhang Q; Zhang YW; Han X; Cao GW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Dec; 34(12):1228-32. PubMed ID: 24518026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.
    Yin J; Wang J; Pu R; Xin H; Li Z; Han X; Ding Y; Du Y; Liu W; Deng Y; Ji X; Wu M; Yu M; Zhang H; Wang H; Thompson TC; Ni W; Cao G
    Cancer Prev Res (Phila); 2015 Oct; 8(10):978-88. PubMed ID: 26290395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-21 receptor gene polymorphism is associated with hepatitis B virus-related hepatocellular carcinoma in Chinese patients.
    Liu T; Song J; Zhang M; Li S; Zhang J; Hu X; Zhao Z; Peng W; Wu Q; Bai H; Li Y; Lu X; Ying B
    J Clin Lab Anal; 2019 Jun; 33(5):e22860. PubMed ID: 30758075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer.
    Zhou H; Gewaily D; Ahn SH; Preskill C; Wang Y; Zong L; Zhang J; Han KH; Wands J; Li J; Tong S
    Virus Res; 2017 May; 235():86-95. PubMed ID: 28373061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan.
    Chen CH; Changchien CS; Lee CM; Tung WC; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
    Int J Cancer; 2009 Aug; 125(3):621-9. PubMed ID: 19431214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.
    Li M; Wang W; Jin R; Zhang T; Li N; Han Q; Wei P; Liu Z
    J Med Virol; 2016 Sep; 88(9):1552-9. PubMed ID: 26889748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.
    Gopalakrishnan D; Keyter M; Shenoy KT; Leena KB; Thayumanavan L; Thomas V; Vinayakumar K; Panackel C; Korah AT; Nair R; Kramvis A
    World J Gastroenterol; 2013 Dec; 19(48):9294-306. PubMed ID: 24409056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus subgenotype C2- and B2-associated mutation patterns may be responsible for liver cirrhosis and hepatocellular carcinoma, respectively.
    Chen YM; Wu SH; Qiu CN; Yu DJ; Wang XJ
    Braz J Med Biol Res; 2013 Jul; 46(7):614-22. PubMed ID: 23903686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of hepatitis B virus isolated from Black South African cancer patients, with and without hepatocellular carcinoma.
    Mak D; Kramvis A
    Arch Virol; 2020 Aug; 165(8):1815-1825. PubMed ID: 32504396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locus 5p13.1 may be associated with the selection of cancer-related HBV core promoter mutations.
    Chen QY; Hu YL; Wang XY; Harrison TJ; Wang C; Hu LP; Yang QL; Ren CC; Jia HH; Fang AZ
    Int J Med Sci; 2019; 16(7):990-997. PubMed ID: 31341412
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma.
    Datta S; Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Roy G; Das S; Das K; Gupta S; Basu K; Basu A; Datta S; Chowdhury A; Banerjee S
    PLoS One; 2014; 9(10):e110012. PubMed ID: 25333524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.
    Liu W; Wu J; Yang F; Ma L; Ni C; Hou X; Wang L; Xu A; Song J; Deng Y; Xian L; Li Z; Wang S; Chen X; Yin J; Han X; Li C; Zhao J; Cao G
    Clin Cancer Res; 2019 Sep; 25(18):5525-5536. PubMed ID: 31152021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between polymorphisms of the
    He XT; Xu HQ; Wang XM; He XS; Niu JQ; Gao PJ
    World J Gastroenterol; 2017 Jan; 23(2):232-241. PubMed ID: 28127197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma in Guangxi population: a case-control study.
    Liu Y; Xie L; Zhao J; Huang X; Song L; Luo J; Ma L; Li S; Qin X
    Medicine (Baltimore); 2015 Apr; 94(13):e702. PubMed ID: 25837767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-21 gene polymorphisms and chronic hepatitis B infection in a Chinese population.
    Yao JY; Chao K; Li MR; Wu YQ; Zhong BH
    World J Gastroenterol; 2015 Apr; 21(14):4232-9. PubMed ID: 25892873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
    Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC
    Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan.
    Kusakabe A; Tanaka Y; Inoue M; Kurbanov F; Tatematsu K; Nojiri S; Joh T; Tsugane S; Mizokami M
    J Gastroenterol; 2011 Jan; 46(1):117-24. PubMed ID: 20820820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.